Pricing Log in Create free account

Citius Oncology, Inc. (CTOR) vs Talphera, Inc. (TLPH)

Citius Oncology, Inc. and Talphera, Inc. are both Drug Manufacturers Specialty & Generic companies. Talphera, Inc. is the larger, with a market value of $52.4M against $46.5M — 1.1× the size. Across the 10 metrics below, Talphera, Inc. leads on 6 and Citius Oncology, Inc. on 4.

Valuation

Metric CTOR TLPH Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S n/m 180.84 2.08
P/B 1.36 5.35 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales n/m 155.68 2.87
Earnings yield (92.16%) (26.47%) (15.94%)
Free cash flow yield (58.41%) (12.52%) 0.00%

Profitability

Metric CTOR TLPH Drug Manufacturers Specialty & Generic median
Gross margin — 100.00% 53.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% (2.45%)
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (126.58%) (143.36%) (0.80%)
Return on assets (45.20%) (69.60%) (1.67%)
Return on invested capital (67.15%) 0.00% 0.00%

Growth

Metric CTOR TLPH Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — (73.07%) 5.22%
EPS growth (last fiscal year) (9.68%) 32.00% 42.91%
Revenue growth, 5-year CAGR — (58.55%) 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CTOR TLPH Drug Manufacturers Specialty & Generic median
Debt to equity 0.50 0.00 0.04
Current ratio 0.73 4.29 2.41
Net debt to EBITDA (0.40) 1.50 1.01

Dividend

Metric CTOR TLPH Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric CTOR TLPH Drug Manufacturers Specialty & Generic median
Market cap 46.50m 52.42m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack